173 related articles for article (PubMed ID: 35011288)
21. In situ "click" assembly of small molecule matrix metalloprotease inhibitors containing zinc-chelating groups.
Hu M; Li J; Yao SQ
Org Lett; 2008 Dec; 10(24):5529-31. PubMed ID: 19053720
[TBL] [Abstract][Full Text] [Related]
22. Comparison of the binding specificity of two bacterial metalloproteases, LasB of Pseudomonas aeruginosa and ZapA of Proteus mirabilis, using N-alpha mercaptoamide template-based inhibitor analogues.
Carson L; Cathcart GR; Ceri H; Walker B; Gilmore BF
Biochem Biophys Res Commun; 2012 Jun; 422(2):316-20. PubMed ID: 22575503
[TBL] [Abstract][Full Text] [Related]
23. The identification of inhibitory compounds of Rickettsia prowazekii methionine aminopeptidase for antibacterial applications.
Helgren TR; Seven ES; Chen C; Edwards TE; Staker BL; Abendroth J; Myler PJ; Horn JR; Hagen TJ
Bioorg Med Chem Lett; 2018 May; 28(8):1376-1380. PubMed ID: 29551481
[TBL] [Abstract][Full Text] [Related]
24. Protease inhibitors: synthesis of matrix metalloproteinase and bacterial collagenase inhibitors incorporating 5-amino-2-mercapto-1,3,4-thiadiazole zinc binding functions.
Scozzafava A; Supuran CT
Bioorg Med Chem Lett; 2002 Oct; 12(19):2667-72. PubMed ID: 12217351
[TBL] [Abstract][Full Text] [Related]
25. Identification of potent and selective MMP-13 inhibitors.
Wu J; Rush TS; Hotchandani R; Du X; Geck M; Collins E; Xu ZB; Skotnicki J; Levin JI; Lovering FE
Bioorg Med Chem Lett; 2005 Sep; 15(18):4105-9. PubMed ID: 16005220
[TBL] [Abstract][Full Text] [Related]
26. Crystal structure of leukotriene A4 hydrolase in complex with kelatorphan, implications for design of zinc metallopeptidase inhibitors.
Tholander F; Roques BP; Fournié-Zaluski MC; Thunnissen MM; Haeggström JZ
FEBS Lett; 2010 Aug; 584(15):3446-51. PubMed ID: 20609366
[TBL] [Abstract][Full Text] [Related]
27. Metalloproteases see the light.
Bogyo M
Nat Chem Biol; 2006 May; 2(5):229-30. PubMed ID: 16619018
[No Abstract] [Full Text] [Related]
28. Apolactoferrin inhibits the catalytic domain of matrix metalloproteinase-2 by zinc chelation.
Newsome AL; Johnson JP; Seipelt RL; Thompson MW
Biochem Cell Biol; 2007 Oct; 85(5):563-72. PubMed ID: 17901898
[TBL] [Abstract][Full Text] [Related]
29. Synthesis and inhibition properties of a series of pyranose derivatives towards a Zn-metalloproteinase from Saccharomonospora canescens.
Dolashka-Angelova P; Abdel-Jalil RJ; Al-Qawasmeh RA; Stambolieva N; Voelter W
Carbohydr Res; 2010 Nov; 345(16):2343-7. PubMed ID: 20801431
[TBL] [Abstract][Full Text] [Related]
30. PAC-1 and isatin derivatives are weak matrix metalloproteinase inhibitors.
Sjøli S; Solli AI; Akselsen O; Jiang Y; Berg E; Hansen TV; Sylte I; Winberg JO
Biochim Biophys Acta; 2014 Oct; 1840(10):3162-9. PubMed ID: 25046380
[TBL] [Abstract][Full Text] [Related]
31. Designing Hydroxamates and Reversed Hydroxamates to Inhibit Zinc-containing Proteases but not Cytochrome P450s: Insights from Quantum Mechanics and Protein-ligand Crystal Structures.
Barker C; Lukac I; Leach AG
Mol Inform; 2015 Sep; 34(9):608-14. PubMed ID: 27490712
[TBL] [Abstract][Full Text] [Related]
32. A bioinorganic perspective on matrix metalloproteinase inhibition.
Puerta DT; Cohen SM
Curr Top Med Chem; 2004; 4(15):1551-73. PubMed ID: 15579096
[TBL] [Abstract][Full Text] [Related]
33. Inhibition of pseudolysin and thermolysin by hydroxamate-based MMP inhibitors.
Adekoya OA; Sjøli S; Wuxiuer Y; Bilto I; Marques SM; Santos MA; Nuti E; Cercignani G; Rossello A; Winberg JO; Sylte I
Eur J Med Chem; 2015 Jan; 89():340-8. PubMed ID: 25462250
[TBL] [Abstract][Full Text] [Related]
34. Specific interactions between zinc metalloproteinase and its inhibitors: Ab initio fragment molecular orbital calculations.
Ara A; Kadoya R; Ishimura H; Shimamura K; Sylte I; Kurita N
J Mol Graph Model; 2017 Aug; 75():277-286. PubMed ID: 28618335
[TBL] [Abstract][Full Text] [Related]
35. Novel Potent Proline-Based Metalloproteinase Inhibitors: Design, (Radio)Synthesis, and First in Vivo Evaluation as Radiotracers for Positron Emission Tomography.
Kalinin DV; Wagner S; Riemann B; Hermann S; Schmidt F; Becker-Pauly C; Rose-John S; Schäfers M; Holl R
J Med Chem; 2016 Oct; 59(20):9541-9559. PubMed ID: 27696839
[TBL] [Abstract][Full Text] [Related]
36. Evidence for restricted reactivity of ADAMDEC1 with protein substrates and endogenous inhibitors.
Lund J; Troeberg L; Kjeldal H; Olsen OH; Nagase H; Sørensen ES; Stennicke HR; Petersen HH; Overgaard MT
J Biol Chem; 2015 Mar; 290(10):6620-9. PubMed ID: 25564618
[TBL] [Abstract][Full Text] [Related]
37. Inhibition of enzyme activity of and cell-mediated substrate cleavage by membrane type 1 matrix metalloproteinase by newly developed mercaptosulphide inhibitors.
Hurst DR; Schwartz MA; Jin Y; Ghaffari MA; Kozarekar P; Cao J; Sang QX
Biochem J; 2005 Dec; 392(Pt 3):527-36. PubMed ID: 16026329
[TBL] [Abstract][Full Text] [Related]
38. Simple pseudo-dipeptides with a P2' glutamate: a novel inhibitor family of matrix metalloproteases and other metzincins.
Devel L; Beau F; Amoura M; Vera L; Cassar-Lajeunesse E; Garcia S; Czarny B; Stura EA; Dive V
J Biol Chem; 2012 Aug; 287(32):26647-56. PubMed ID: 22689580
[TBL] [Abstract][Full Text] [Related]
39. Enhanced potency of the metalloprotease inhibitor TAPI-2 by multivalent display.
Raissi AJ; Scangarello FA; Hulce KR; Pontrello JK; Paradis S
Bioorg Med Chem Lett; 2014 Apr; 24(8):2002-7. PubMed ID: 24581919
[TBL] [Abstract][Full Text] [Related]
40. Destructive twisting of neutral metalloproteases: the catalysis mechanism of the Dispase autolysis-inducing protein from Streptomyces mobaraensis DSM 40487.
Fiebig D; Storka J; Roeder M; Meyners C; Schmelz S; Blankenfeldt W; Scrima A; Kolmar H; Fuchsbauer HL
FEBS J; 2018 Nov; 285(22):4246-4264. PubMed ID: 30171661
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
